PeptiMatrix supplies a synthetic peptide hydrogel platform for 3D cell culture that supports customizable animal-free models.
PeptiMatrix has raised $436K in total funding. The most recent round was Grant. The last funding was announced in July 2023.
PeptiMatrix's investors include Innovate UK, University of Nottingham.
PeptiMatrix is headquartered in Nottingham, United Kingdom.
PeptiMatrix supplies a synthetic peptide hydrogel platform for 3D cell culture that supports customizable animal-free models.
PeptiMatrix is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"PeptiMatrix — Funding & Investors." VCBacked, July 4, 2023, https://www.vcbacked.co/company/peptimatrix. Accessed September 30, 2026.
VCBacked. (2023). PeptiMatrix — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/peptimatrix
{{cite web |title=PeptiMatrix — Funding & Investors |url=https://www.vcbacked.co/company/peptimatrix |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated